UMIP Wins Tech Transfer Award
The University of Manchester’s intellectual property commercialisation company, UMIP, was voted Technology Transfer Office of the Year at the Genesis biotechnology conference in London last week.
The judges at the Gala dinner, held at the Queen Elizabeth II Conference Centre, awarded UMIP the top prize, despite strong competition from the other two shortlisted companies; Cancer Research Technology Ltd and UCL Business plc.
Commenting on the award Clive Rowland, CEO of UMIP, said: “It is an honour to receive this award and it is testament to all the dedication and hard work of UMIP staff. It has been a strong year for us with many new technologies having been either licensed or spun-out creating companies to bring ground breaking new technologies to the marketplace.“
In financial terms, over the last 5 years, UMIP’s activities have generated over £35M for the University through the sale of shares in spin-outs, licensing income and through IP grants and contracts activity.
This year UMIP has seen award-winning Myconostica pick up the ‘Innovation in Diagnostics Project of the Year’ prize at the Northwest Biomedical Awards. Also, spin out company Renephra received the ‘Emerging Technology Project of the Year’ at the same ceremony, as well as the ‘Northwest NHS Innovations Award’ at a separate event.
Also, clean-tech spin-out company Arvia® Technology won the Institution of Engineering and Technology’s (IET) North West Innovation Award in July and were named a Global Cleantech 100 company by Guardian News and Media and Cleantech Group™.
Press contact: Clare Coyne, Roland Dransfield PR, 0161 236 1122
UMIP
The University of Manchester Intellectual Property Limited (UMIP) is the managing agent of The University of Manchester for intellectual property commercialisation. UMIP’s role is to enhance the reputation of the University’s intellectual property development through successful spin-out and licensing business activities.
UMIP consists of faculty oriented business management teams backed up by a central corporate office which provides company secretarial, marketing, legal and financial expertise.
Its activities include:
· Manages Intellectual Property on behalf of the University.
· Identifies, protects and evaluates the commercial potential of research from all faculties.
· Commercialises Intellectual Property via the most appropriate route: sale, licence or spin-out.
· Holds the University’s patent budget and manages its Proof of Principle awards and provides access to spin-out investment funds via The UMIP Premier Fund.
· Has access to an extensive network of industry experts, professional advisers and investors.
Since its inception in October 2004, UMIP has set up sixteen spin-out companies, concluded over 80 licence deals and raised more than £130 million in investment capital. It currently has over 100 projects in its portfolio at various stages of development. A number of the spin-out companies have received national and regional enterprise awards.
UMIP is wholly owned by The University of Manchester and has over a 20 year history of IP commercialisation and is a limited company of over 35 employees.
For more information visit www.umip.com
